新型出生前診断（NIPT）の世界市場予測（～2021）...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Assumptions for the Study

3 Executive Summary (Page No. – 26)

4 Premium Insights (Page No. – 30)
4.1 Non-Invasive Prenatal Testing Market: Overview
4.2 NIPT Consumables Market Size, By Type, 2016 vs 2021 (USD Million)
4.3 NIPT Instruments Market Size, By Type, 2016 vs 2021 (USD Million)
4.4 Geographic Analysis: Market, By Method (2016)
4.5 NIPT Market, By Application (2016–2021)
4.6 Non-Invasive Prenatal Testing Market Size, By End User, 2016 vs 2021 (USD Million)
4.7 Geographic Snapshot (2016–2021)

5 Market Overview (Page No. – 34)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 High Risk of Chromosomal Abnormalities With Increasing Maternal Age
5.1.1.2 Growing Preference for Non-Invasive Techniques Over Invasive Methods
5.1.1.3 Launch of New and Advanced Products
5.1.1.4 Improving Reimbursement Scenario for NIPT
5.1.1.5 Programs Focusing on Increasing the Awareness of NIPT
5.1.2 Restraint
5.1.2.1 Lack of Skilled Professionals
5.1.3 Opportunity
5.1.3.1 Untapped Emerging Markets
5.1.4 Challenge
5.1.4.1 Reliability of Test Results Especially in Obese Women

6 Non-Invasive Prenatal Testing Market, By Product (Page No. – 41)
6.1 Introduction
6.2 Consumables
6.2.1 Assay Kits & Reagents
6.2.2 Disposables
6.3 Instruments
6.3.1 Ultrasound Devices
6.3.2 Next-Generation Sequencing Systems
6.3.3 Polymerase Chain Reaction Instruments
6.3.4 Microarrays
6.3.5 Other Instruments

7 Non-Invasive Prenatal Testing Market, By Method (Page No. – 52)
7.1 Introduction
7.2 Ultrasound Detection
7.3 Biochemical Screening Tests
7.4 Cell-Free Dna in Maternal Plasma Tests
7.5 Fetal Cells in Maternal Blood Tests

8 Non-Invasive Prenatal Testing Market, By Application (Page No. – 62)
8.1 Introduction
8.2 Trisomy
8.3 Microdeletion Syndrome
8.4 Other Applications

9 Non-Invasive Prenatal Testing Market, By End User (Page No. – 69)
9.1 Introduction
9.2 Diagnostic Laboratories
9.3 Hospitals

10 Non-Invasive Prenatal Testing Market, By Region (Page No. – 75)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Rest of Europe (RoE)
10.4 Asia
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 104)
11.1 Overview
11.2 Market Analysis
11.3 Competitive Situation and Trends
11.3.1 Partnerships, Collaborations, & Agreements
11.3.2 Product Launches
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Strategies

12 Company Profile (Page No. – 112)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Ge Healthcare (A Wholly Owned Subsidiary of General Electric Company)
12.3 Koninklijke Philips N.V.
12.4 Illumina, Inc.
12.5 Thermo Fisher Scientific, Inc.
12.6 F. Hoffman-La Roche Ltd.
12.7 Pacific Biosciences of California, Inc.
12.8 Perkinelmer, Inc.
12.9 Qiagen N.V.
12.10 Agilent Technologies, Inc.
12.11 Beijing Genomics Institute

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 141)
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details